Found: 8
Select item for more details and to access through your institution.
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35378-z
- By:
- Publication type:
- Article
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03296-x
- By:
- Publication type:
- Article
Context-dependent deposition and regulation of mRNAs in P-bodies.
- Published in:
- eLife, 2018, p. 1, doi. 10.7554/eLife.29815
- By:
- Publication type:
- Article
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01510-z
- By:
- Publication type:
- Article
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens.
- Published in:
- Nucleic Acids Research, 2021, v. 49, n. 15, p. 8488, doi. 10.1093/nar/gkab627
- By:
- Publication type:
- Article
Improved pathway reconstruction from RNA interference screens by exploiting off-target effects.
- Published in:
- Bioinformatics, 2018, v. 34, n. 13, p. i519, doi. 10.1093/bioinformatics/bty240
- By:
- Publication type:
- Article
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03296-x
- By:
- Publication type:
- Article